@Diego2 - Studie zu EGCG und Lungenfibrose

Sligo, Mittwoch, 22.04.2020, 18:17 (vor 1477 Tagen) @ Diego22262 Views

Hallo Diego,

gerade veröffentlicht:

'Taking oral dietary supplements of epigallocatechin-3-gallate (EGCG) — an antioxidant in green tea — may stop and reverse the pro-fibrotic (scarring) state of the lungs of people with idiopathic pulmonary fibrosis (IPF), a small study suggests.

These early findings support larger studies of EGCG’s anti-fibrotic potential in IPF, which if confirmed, would place EGCG as a therapy candidate for this patient population.'

https://pulmonaryfibrosisnews.com/2020/04/21/green-tea-extract-stops-anti-fibrotic-proc...

Das Produkt

http://www.teavigoinfo.com/teavigo-green-tea.html

wird in Deutschland von der Taiyo GmbH in Schwelm vertrieben.

https://taiyogmbh.com/en/brands/

Unter Umständen interessant.

Gruss,

Sligo


gesamter Thread:

RSS-Feed dieser Diskussion

Werbung